Literature DB >> 16100642

NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases.

Thomas F Baskett1, Heidi Clough, Tracy A Scott.   

Abstract

OBJECTIVE: To review the perioperative complications and short-term outcome in women undergoing endometrial ablation for menorrhagia using the NovaSure bipolar radiofrequency impedance-controlled system.
METHODS: We conducted a prospective observational study of endometrial ablation using the NovaSure system in 200 women with menorrhagia not amenable to medical management.
RESULTS: Of the 200 women treated, 146 have been observed for 1 to 4 years with the following outcomes related to menstrual bleeding: amenorrhea 43.1%, light bleeding 41.8%, normal bleeding 4.1%, and heavy bleeding 11%. Twelve of the 146 women (8.2%) required repeat surgical treatment: hysterectomy in 10 cases and repeat ablation in 2. In the 200 cases, 1 laparoscopy was performed because of uterine perforation at the time of pretreatment hysteroscopy, and 2 patients required antibiotic therapy for postoperative endomyometritis. Of the women observed for 1 to 4 years, 81.5% felt the procedure was successful, and 97.3% would recommend the procedure to a friend.
CONCLUSION: Endometrial ablation using the NovaSure system is a simple technique in the normal uterine cavity, which can be performed under local anaesthesia and conscious sedation. The complication rate is low, and the short-term satisfaction and results are good.

Entities:  

Mesh:

Year:  2005        PMID: 16100642     DOI: 10.1016/s1701-2163(16)30530-8

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  9 in total

Review 1.  Endometrial ablation for heavy menstrual bleeding.

Authors:  Vinod Kumar; Rohan Chodankar; Janesh Kumar Gupta
Journal:  Womens Health (Lond)       Date:  2016-01-12

Review 2.  Ambulatory management of heavy menstrual bleeding.

Authors:  Attilio Di Spiezio Sardo; Marialuigia Spinelli; Brunella Zizolfi; Carmine Nappi
Journal:  Womens Health (Lond)       Date:  2015-12-23

3.  Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.

Authors:  Jeffrey D Miller; Gregory M Lenhart; Machaon M Bonafede; Cindy M Basinski; Andrea S Lukes; Kathleen A Troeger
Journal:  Int J Womens Health       Date:  2015-01-06

Review 4.  Late-onset endometrial ablation failure.

Authors:  Morris Wortman
Journal:  Case Rep Womens Health       Date:  2017-07-12

5.  Novasure as a mechanical endometrial preparation agent in large uteri.

Authors:  Sushma Potti; Shitanshu Uppal; Ashwin J Chatwani; Enrique Hernandez; Vani Dandolu
Journal:  JSLS       Date:  2012 Oct-Dec       Impact factor: 2.172

6.  Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases.

Authors:  Oluwole Fadare; Sa A Wang; Idris L Renshaw
Journal:  Diagn Pathol       Date:  2008-07-01       Impact factor: 2.644

Review 7.  Ten-year literature review of global endometrial ablation with the NovaSure® device.

Authors:  Richard J Gimpelson
Journal:  Int J Womens Health       Date:  2014-03-11

8.  Efficacy and patient satisfaction after NovaSure and Minerva endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study.

Authors:  Constantine Scordalakes; Robert delRosario; Andrew Shimer; Russell Stankiewicz
Journal:  Int J Womens Health       Date:  2018-04-18

9.  Pathological findings in the endometrium after microwave endometrial ablation.

Authors:  Kentaro Nakayama; Sultana Razia; Tomoka Ishibashi; Masako Ishikawa; Hitomi Yamashita; Kohei Nakamura; Kiyoka Sawada; Yuki Yoshimura; Nagisa Tatsumi; Sonomi Kurose; Toshiko Minamoto; Kouji Iida; Noriyoshi Ishikawa; Satoru Kyo
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.